Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines

Oncogene

Volumn 18, Issue 3, 1999, Pages 837-842

  Kato, Masashi ^a   Liu, Wei ^a   Akhand, Anwarul A ^a   Dai, Yan ^a   Ohbayashi, Masaharu ^a   Tuzuki, Toyonori ^a   Suzuki, Haruhiko ^a   Isobe, Ken Ichi ^a,b   Takahashi, Masahide ^a   Nakashima, Izumi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHUBU NATIONAL HOSPITAL   (Japan)

Author keywords

Immune surveillance; Melanocytic tumor; Metallothionein I ret transgenic mouse lines; Oncogene product specific tolerance; Ret protein expression

Indexed keywords

METALLOTHIONEIN; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; BRAIN; CONTROLLED STUDY; ENHANCER REGION; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA; MELANOSIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; THYMUS; TRANSGENIC MOUSE;

ANIMALS; DROSOPHILA PROTEINS; HUMANS; LINKAGE (GENETICS); MELANOCYTES; METALLOTHIONEIN; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; SKIN NEOPLASMS;

ANIMALIA; MUS MUSCULUS;

EID: 0033590625     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202329     Document Type: Article

References (21)

1. Asai N, Iwashita T, Matsuyama M and Takahashi M. (1995). Mol. Cell Biol., 15, 1613-1619.
2. Campbell AE, Foley FL and Tevethia SS. (1993). J. Immunol., 130, 490-492.
3. Chen L, Thomas EK, Hu SL, Hellstrom I and Hellstrom KE. (1991). Proc. Natl. Acad. Sci. USA, 88, 110-114.
4. Corradin G, Etlinger HM and Chiller JM. (1977). J. Immunol., 119, 1048-1053.
5. Dai Y, Isobe K, Takahashi M and Nakashima I. (1994). Int. J. Oncol., 5, 661-665.
6. Faas S, Pan S, Pinkert C, Brinster R and Knowles B. (1987). J. Exp. Med., 165, 417-427.
7. Ichihara M, Iwamoto T, Isobe K, Takahashi M, Nakayama A, Pu M, Dai Y, Parashar A, Ohkus K, Kato M, Hotta T and Nakashima I. (1995). Br. J. Cancer, 71, 808-813.
8. Iwamoto T, Takahashi M, Ito M, Hamatani K, Ohbayashi M, Wajjwalku W, Isobe K and Nakashima I. (1991). EMBO J., 11, 3167-3175.
9. Jung S and Schluesener HJ. (1991). J. Exp. Med., 173, 273-276.
10. Kast WM, Offringa R, Peters PJ, Voordouw AC, Meloen RH, Van der Eb AJ and Melief CJ. (1989). Cell, 59, 603-614.
11. Kato M, Pu M, Isobe K, Hattori T, Yanagita N and Nakashima I. (1995). Immunopharmacology, 29, 207-213.
12. Kato M, Pu M, Isobe K, Iwamoto T, Nagase F, Lwin T, Zhang YH, Hattori T, Yanagita N and Nakashima I. (1994). Cell Immunol., 159, 15-25.
13. Mosmann TR, Schumacher JH, Street NF, Budd R, O'Garra A, Fong TAT, Bond MW, Moore KW, Sher A and Fiorentino DF. (1991). Immunol. Rev., 123, 209-229.
14. Nakashima I, Mizoguchi K, Kato N, Nagase F, Isobe K, Saito M and Suzuki K. (1982). Eur. J. Immunol., 12, 713-719.
15. Schrmberk R, Zerrahn J, Kuhrober A, Kury E, Deppert W and Reimann J. (1992). Eur. J. Immunol., 22, 759-766.
16. Takahashi M, Asai N, Iwashita T, Isomura K, Miyazaki K and Matsuyama M. (1993). Oncogene, 8, 2925-2929.
17. Takahashi M, Buma Y and Taniguchi M. (1991). Oncogene, 6, 297-301.
18. Taniguchi M, Iwamoto T, Nakashima I, Nakayama A, Ohbayashi M, Matsuyama M and Takahashi M. (1992). Oncogene, 7, 1491-1496.
19. Tevethia SS, Flyer DC and Tjian R. (1980). Virology, 107, 13-23.
20. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M and Asai J. (1995). Oncogene, 10, 191-198.
21. Yanuck M, Carbone D, Pendleton CD, Tsukui T, Winter SF, Minna JD and Berzofsky JA. (1993). Cancer Res., 53, 3257-3261.